Evidence map›Paper›PMID 40125376›Full record

ArticleHealth equity2024

A Conceptual Model to Achieve Health Equity in APOL-1 Clinical Studies.

Raven A Hardy Richard, Rebecca Hayes, Robert Flemming, Cesia Portillo, Richardae Araojo, Christine Lee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Health equity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Raven A Hardy RichardOffice of Minority Health and Health Equity (OMHHE), Food and Drug Administration, Silver Spring, Maryland, USA.ORCID https://orcid.org/0000-0001-5438-5848
Rebecca HayesNorth Carolina Community Health Center Association, Raleigh, North Carolina, USA.
Robert FlemmingDepartment of the Air Force, Washington, District of Columbia, USA.
Cesia PortilloAmerican Society of Nephrology, Washington, District of Columbia, USA.
Richardae AraojoOffice of Minority Health and Health Equity (OMHHE), Food and Drug Administration, Silver Spring, Maryland, USA.
Christine LeeOffice of Minority Health and Health Equity (OMHHE), Food and Drug Administration, Silver Spring, Maryland, USA.ORCID https://orcid.org/0000-0001-8953-4823

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The socioecological model (SEM) conceptualizes health broadly and focuses on multiple factors that might affect health. This article takes a novel approach to leverage an SEM framework to identify challenges and sustainable opportunities to advance diversity for clinical study participation in apolipoprotein L1 (APOL-1)-mediated kidney disease. We describe four levels of an APOL-1 SEM-intrapersonal, interpersonal, community, and structures/systems-for improved diverse APOL-1 clinical study enrollment and engagement. This SEM can serve as a model for improving clinical study diversity and equity to help improve the generalizability of clinical study results in other disease conditions that disproportionally impact racial and ethnic minority populations.

Indexed as

APOL-1clinical trialshealth disparitieshealth equityminority health

Identifiers

PMID40125376
PMCPMC11512090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.